Back to Search
Start Over
PSS15 REAL-WORLD COSTS IN BIOLOGIC NAIVE PSORIATIC ARTHRITIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE.
- Source :
-
Value in Health . 2019 Supplement 3, Vol. 22, pS888-S888. 1p. - Publication Year :
- 2019
-
Abstract
- In all, 1,471 biologic-naive PsA patients initiating apremilast were matched to 890 biologic-naive PsA patients initiating biologics (TNF: n=804; IL: n=86). Biologic-naive PsA patients initiating apremilast had significantly lower healthcare costs than patients initiating biologics in a US claims database. [Extracted from the article]
- Subjects :
- *PSORIATIC arthritis
*MEDICAL databases
*BIOLOGICALS
Subjects
Details
- Language :
- English
- ISSN :
- 10983015
- Volume :
- 22
- Database :
- Academic Search Index
- Journal :
- Value in Health
- Publication Type :
- Academic Journal
- Accession number :
- 140398763
- Full Text :
- https://doi.org/10.1016/j.jval.2019.09.2577